Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency

BACKGROUND: Discontinuing growth hormone (GH) treatment during the transition to adulthood has been associated with adverse health outcomes in patients with childhood-onset growth hormone deficiency (CO-GHD). This study investigated the metabolic changes associated with interrupting GH treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yun Jeong, Choi, Yunha, Yoo, Han-Wook, Lee, Young Ah, Shin, Choong Ho, Choi, Han Saem, Kim, Ho-Seong, Kim, Jae Hyun, Moon, Jung Eun, Ko, Cheol Woo, Ahn, Moon Bae, Suh, Byung-Kyu, Choi, Jin-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081298/
https://www.ncbi.nlm.nih.gov/pubmed/35504604
http://dx.doi.org/10.3803/EnM.2021.1384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081298/
https://www.ncbi.nlm.nih.gov/pubmed/35504604
http://dx.doi.org/10.3803/EnM.2021.1384

Ejemplares similares